The Digital Analytics Association announced several new officers and appointees to its Board of Directors.
For years, Genzyme Corp. has operated a two-track email program to maintain contact with consumers interested in its Synvisc-One treatment for osteoarthritis of the knee. However, its email opt-in form failed to deliver, says Christine Waite, director of Synvisc-One patient marketing at Genzyme.
Google + is more than just a new social network and a chink in Facebook's armor—it's a critical piece of the Google puzzle. Google won't stop until it gets it right, and when that happens, I think we'll see a significant shift in our digital universe, which will have a defining impact on the landscape for marketers, brands, start-ups, consumers and the creative services industry.
Company of the Week
SK&A is a leading provider of U.S. healthcare information solutions and databases. As part of IMS Health, SK&A researches and maintains contact and profiling data for over 2 million healthcare providers, including 800,000+ prescribers. SK&A's data supports research and marketing initiatives for life sciences, medical device, managed healthcare, direct marketing, publishing, education and more. SK&A's proprietary databases are telephone-verified twice per year from its world class Research Centers. SK&A enables multi-channel marketing and sets the standard for data quality and reliability. SK&A's customers include many of America's most recognized healthcare, publishing and pharmaceutical institutions.
SK&A is a leading provider of U.S. healthcare information solutions and databases. As ...